Structural and Functional Characterization of Deceased Donor Stem Cells: A Viable Alternative to Living Donor Stem CellsSTEM CELLS INTERNATIONALIF3.32019-11-254OAAI
Facilitating successful donor heart allocations in highly sensitized recipients using new flow cytometry crossmatch methodology.TRANSPLANTATIONIF52019-11-010OAAI
Procurement of Stem Cells from Deceased Donor Bone Marrow: A Viable Alternative to Living DonorsTRANSPLANTATIONIF52019-09-010OAAI
Deceased Donor Adipose Tissue: An Untapped Source of Mesenchymal Stem CellsTRANSPLANTATIONIF52019-09-010PREAI
TRANSPLANT TOLERANCE IN HEART TRANSPLANT RECIPIENTS: IT IS ALL IN THE GENESHUMAN IMMUNOLOGYIF2.22016-09-010PREAI
IgG Subtyping in Heart Transplantation Across a Positive Flow-Cytometry Cross MatchJOURNAL OF CARDIAC FAILUREIF8.22016-08-010OAAI
Lack of Rejection Despite Period of No Immunosuppression: The NoTac Case SeriesJOURNAL OF HEART AND LUNG TRANSPLANTATIONIF62016-04-010OAAI
PREDICTING DONOR SPECIFIC CROSSMATCH OUTCOME USING AN IN-HOUSE GENERATED VIRTUAL CROSSMATCH ALGORITHM.HUMAN IMMUNOLOGYIF2.22015-10-010PREAI
Survival Without Immunosuppression: The NoTAC TrialJOURNAL OF HEART AND LUNG TRANSPLANTATIONIF62015-04-010PREAI
Small-molecule inducer of cancer cell polyploidy promotes apoptosis or senescence Implications for therapyCELL CYCLEIF3.42014-10-3128OAAI
Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerizationPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12012-06-28220OA
Pharmacologic p53 Activation Blocks Cell Cycle Progression but Fails to Induce Senescence in Epithelial Cancer CellsMOLECULAR CANCER RESEARCHIF4.72009-09-1772PREAI